TP53 and non-small cell lung carcinoma: Aware that female patients diagnosed with NSCLC were reported to outlive their male counterparts in Australia and the US in recent statistics [12], we were curious to examine whether this held for its main component subtypes, LUAD and LUSC, and whether this is connected to TP53 status.